Skip to content
TRT.med

Treatment Index

TRT Treatments

A conservative overview of common medication categories and related options people compare in TRT-focused care. Sorted by evidence strength.

Informational only; consult a clinician. This content does not constitute medical advice and is not a substitute for professional diagnosis or treatment.

InjectionFDA-approved products exist for diagnosed hypogonadism
Strong Evidence

Testosterone Injections

Injectable testosterone is a common treatment route in TRT programs when clinically indicated. Product selection and follow-up cadence are clinician-directed.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by product, clinic model, and monitoring requirements.
View details
TopicalFDA-approved products exist for diagnosed hypogonadism
Strong Evidence

Testosterone Topical (Gel/Cream/Solution)

Topical testosterone options are used in some TRT plans when a non-injection route is preferred or clinically appropriate.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by formulation, brand, and refill logistics.
View details
PatchFDA-approved products exist for diagnosed hypogonadism
Moderate Evidence

Testosterone Patch

Patch-based testosterone delivery is an alternative route in selected TRT plans and may differ operationally from gels or injections.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by product coverage and pharmacy channel.
View details
PelletFDA-approved products exist for diagnosed hypogonadism
Moderate Evidence

Testosterone Pellets

Pellet-based delivery is used in some in-person care models and usually involves procedure-based workflows.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeOften bundled with procedure and follow-up costs.
View details
NasalFDA-approved products exist for diagnosed hypogonadism
Moderate Evidence

Testosterone Nasal

Nasal testosterone is another route that may be discussed depending on diagnosis, tolerability, and access.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by formulation availability and benefit design.
View details
OralFDA-approved products exist for diagnosed hypogonadism
Moderate Evidence

Oral Testosterone Undecanoate

Oral testosterone undecanoate products may appear in TRT options for selected patients when clinically appropriate.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by product coverage, pharmacy access, and plan structure.
View details
OralNot FDA-approved for TRT use-case
Moderate Evidence

Clomiphene (Overview)

Some clinics discuss clomiphene in testosterone-related care pathways. Its use in TRT contexts is generally off-label and should be explained clearly.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by clinic, pharmacy channel, and monitoring plan.
View details
InjectionNot FDA-approved for TRT use-case
Limited Evidence

hCG (Overview)

hCG may be discussed in some testosterone-care pathways. Its role is context-dependent and should not be assumed equivalent to testosterone replacement.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries by source, dispensing pathway, and monitoring intensity.
View details
OralNot FDA-approved for TRT use-case
Limited Evidence

Aromatase Inhibitors (Overview)

Aromatase inhibitors may be discussed in some hormone-management plans. They are not FDA-approved specifically for TRT use-cases.

Typical doseNo dosing guidance is provided on TRT.med.
Price rangeVaries; often discussed as adjunctive therapy in select scenarios.
View details
Strong evidenceModerate evidenceLimited evidence
Compare options